Question follow-through · 11195
General Practitioners: Finance
To ask the Secretary of State for Health and Social Care, what the planned timetable is for the complete conclusion of the review of the Carr-Hill formula, and the publication of its findings.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 18 Jun 2026
- Target answer date
- 22 Jun 2026
- Answer
- 30 Jun 2026 · 12 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Leukaemia: Diagnosis · 30 Jun 2026
- Steroid Drugs · 30 Jun 2026
- General Practitioners: Hinckley and Bosworth · 30 Jun 2026
- Steroid Drugs: Men · 30 Jun 2026
- Marriage: Relatives · 6 Jul 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
18 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what the planned timetable is for the complete conclusion of the review of the Carr-Hill formula, and the publication of its findings.
22 Jun 2026
Target answer date
Date supplied by the official written-questions record.
30 Jun 2026
Answer published
Phase 1 of the Carr-Hill review concluded in May 2026. The report and recommendations are currently with the Department for consideration. The review’s findings and recommendations will be published in due course by the National Institute for Health and C...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Leukaemia: Diagnosis
30 Jun 2026 · To ask the Secretary of State for Health and Social Care, what recent steps he has taken to support the national rollout of the Leukaemia Best Practice Timed Pathway.
Steroid Drugs
30 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will hold discussions with (a) local and national health bodies, (b) academics and (c) the Men's Health Strategy Stakeholder Group on the issues surrounding Anabolic Steroids, IPEDs and SARMS
General Practitioners: Hinckley and Bosworth
30 Jun 2026 · To ask the Secretary of State for Health and Social Care, to ask the Secretary of State for Health and Social Care, with reference to the Prime Minister's oral contribution of 29 April 2026, official report, Volume 784, column 895, what is the evidential
Steroid Drugs: Men
30 Jun 2026 · To ask the Secretary of State for Health and Social Care, pursuant to WPQ 9089 answered on 19 June 2026 about Steroid Drugs: Young People, if he will hold discussions with [i] local and national health bodies, [ii] academics and [iii] the Men's Health Str
Marriage: Relatives
6 Jul 2026 · To ask the Secretary of State for Health and Social Care, pursuant to WPQ 106603 answered on 26 January 2026 about Marriage Relatives, what recent discussions the National Disease Registration Service has had with hospital trusts on improve the quality an
Menopause: Drugs
7 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure consistent access across Integrated Care Boards to non-hormonal menopause treatments, including fezolinetant.
Fezolinetant
7 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether national guidance has been issued to Integrated Care Boards on the prescribing of fezolinetant following its approval for NHS use.
Fezolinetant
7 Jul 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of levels of regional variation in access to fezolinetant across England.
Prescription Drugs
7 Jul 2026 · To ask the Secretary of State for Health and Social Care, what guidance exists on shared care arrangements for patients seeking to transition from privately obtained medication to NHS prescriptions where those treatments later become available on the NHS.
Health Services
7 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients are not disadvantaged when accessing NHS care after accessing treatment privately due to a previous lack of NHS availability.
Fezolinetant
7 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether he has had discussions with NHS England on access to fezolinetant within Leicester, Leicestershire and Rutland Integrated Care Board.
Medicine: Higher Education
8 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether NHS England continues to collect annual accountability reports from NHS trusts on the expenditure of undergraduate medical tariff funding.